Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...

Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.

The University of Wisconsin–Madison and Immuto Scientific have teamed up to explore new therapeutic targets in colorectal ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

Colon cancer has been making headlines recently, with more young people being diagnosed with the disease. But now, a groundbreaking new study is offering hope for patients. In a first-of-its-kind ...

CINCINNATI, Ohio. (Ivanhoe Newswire) — Rectal cancer cases are climbing in the U.S., now striking almost 47,000 people every year. When you add all types of colorectal cancer, that number soars past ...

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the ...